Organon & Co. (OGN): Financials
Trailing 12 months ended June 30, 2026
Income statement, cash flow and balance sheet figures for Organon & Co. (OGN), read directly from the XBRL data the company files with the SEC. Over the trailing twelve months the company reported $6.1B of revenue, down 2.5% year over year. Net income was $209.0M, or $0.78 per diluted share. Free cash flow was $567.0M. Gross margin stood at 52.7%.
Against the current share price, OGN trades at 17.6 times trailing earnings and 0.6 times trailing revenue.
7 fiscal years of history are available, back to 2019.
Frequently asked questions
How much revenue does OGN make?
Organon & Co. reported $6.1B of revenue over the trailing twelve months, for the period ended June 30, 2026. That is down 2.5% from the same period a year earlier.
Is OGN profitable?
Organon & Co. was profitable over the trailing twelve months, earning $209.0M of net income, a net margin of 3.4%.
Where does this financial data come from?
Every figure on this page is read from the company's own SEC 10-Q and 10-K filings. Nothing is estimated by a third party. Quarterly figures a company does not file separately (most commonly the fourth quarter) are derived by subtracting the reported year-to-date quarters from the full fiscal year, and are labelled as derived.
What is the difference between quarterly, annual and TTM?
Quarterly shows each three-month fiscal period on its own. Annual shows the full fiscal year as filed in the 10-K. TTM (trailing twelve months) sums the last four reported quarters, which is the most current annualised view between 10-K filings.